Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters










Database
Language
Publication year range
2.
J Cardiovasc Med (Hagerstown) ; 16 Suppl 1: S38-41, 2015 Jan.
Article in English | MEDLINE | ID: mdl-21178637

ABSTRACT

Cardiac complications of high-dose cytosine arabinoside (HiDAC), although rare, predominantly include pericarditis, pericardial effusion and cardiomyopathy (with concurrent use of cyclophosphamide). Clinically significant arrhythmias associated with HiDAC, although reported in the literature, are rare. The following case report has for the first time used the Naranjo Scale to document a high-probability association (definite adverse drug reaction) of cytarabine with symptomatic sinus bradycardia.


Subject(s)
Antimetabolites, Antineoplastic/adverse effects , Bradycardia/chemically induced , Bradycardia/diagnosis , Cytarabine/adverse effects , Electrocardiography , Bradycardia/physiopathology , Cytarabine/administration & dosage , Dose-Response Relationship, Drug , Female , Humans , Middle Aged
3.
Int J Clin Oncol ; 17(4): 399-406, 2012 Aug.
Article in English | MEDLINE | ID: mdl-21892669

ABSTRACT

The Ewing's family of tumors (EFT) comprises a molecularly defined group of "small round blue cell tumors", consisting of Ewing's sarcoma of bone (ESB), extraosseous Ewing's sarcoma (EES), peripheral primitive neuroectodermal tumor (pPNET), and Askin's tumor. Characteristic translocations that disrupt the EWSR1 gene located at 22q12 create novel fusion genes that are central to the pathogenesis. The EFT also shares certain clinical characteristics, such as a peak incidence during the teenage years, a tendency to spread rapidly, and responsiveness to the same chemotherapeutic regimens and radiation therapy. Nearly all patients have occult disseminated disease at diagnosis; hence, chemotherapy is routinely used. Improvements in multimodality treatment have had a dramatic impact on outcomes. EES/pPNET has been reported in a variety of sites, including the pancreas, though this is extremely rare. We describe a case of pancreatic EES/pPNET in a 35-year-old woman and provide a brief review of the relevant literature.


Subject(s)
Combined Modality Therapy , Neuroectodermal Tumors, Primitive , Pancreatic Neoplasms , Sarcoma, Ewing , Adult , Calmodulin-Binding Proteins/genetics , Chromosomes, Human, Pair 22 , Doxorubicin/administration & dosage , Female , Follow-Up Studies , Humans , Neoplasm Staging , Neuroectodermal Tumors, Primitive/genetics , Neuroectodermal Tumors, Primitive/pathology , Neuroectodermal Tumors, Primitive/surgery , Pancreatic Neoplasms/genetics , Pancreatic Neoplasms/pathology , Pancreatic Neoplasms/surgery , RNA-Binding Protein EWS , RNA-Binding Proteins/genetics , Sarcoma, Ewing/genetics , Sarcoma, Ewing/pathology , Sarcoma, Ewing/surgery , Translocation, Genetic
4.
Cancer Imaging ; 11: 140-3, 2011 Sep 24.
Article in English | MEDLINE | ID: mdl-22004872

ABSTRACT

The diagnosis of leptomeningeal carcinomatosis remains difficult despite improvement in central nervous system (CNS) imaging and cytologic examination of the cerebral spinal fluid. False-negative results are common, providing obstacles in assessing both prophylactic and therapeutic efforts. As a result of increased survival of patients with a variety of systemic neoplasms it is likely that central nervous involvement will need to be addressed more often. This article presents a patient with a diffuse large B-cell lymphoma with polymorphic features. Imaging using 18F-labeled fluorodeoxythymidine (FLT) proved useful in demonstrating both parenchymal and leptomeningeal CNS involvement. The potential for FLT to identify proliferative tissue may make it uniquely suitable for detection of CNS malignant disease.


Subject(s)
Dideoxynucleosides , Lymphoma, Large B-Cell, Diffuse/diagnostic imaging , Meningeal Neoplasms/diagnostic imaging , Positron-Emission Tomography/methods , Radiopharmaceuticals , Female , Humans , Middle Aged
5.
J Clin Apher ; 26(3): 156-8, 2011.
Article in English | MEDLINE | ID: mdl-21647954

ABSTRACT

Cyclosporine is commonly used as an immunosuppressive agent in both solid organ and bone marrow transplant. While used for graft rejection in organ transplantation, cyclosporine has been used to enable tolerance and for prevention of acute graft-versus-host disease in bone marrow transplant [Ratanatharathorn et al., Blood 1998;92:2303-2314]. Cyclosporine has a narrow therapeutic window, and many patients develop some level of toxicity even within the therapeutic range. Common toxicities include hypertension, nephrotoxicity, electrolyte abnormalities, hyperglycemia, and neurotoxicity [Woo et al., Bone Marrow Transplant 1997;20:1095-1098]. Management of cyclosporine toxicity is not clearly defined and is primarily supportive in nature. In cases of significant elevations of cyclosporine levels, limited data are available but suggest that whole blood exchange may be effective [Kwon et al., J Heart Lung Transplant 2006;25:483-485; Leitner et al., Transplantation 2003;75:1764-1765]. We present a case of successful rapid clearance of cyclosporine utilizing a combined approach of red cell exchange and plasma exchange.


Subject(s)
Cyclosporine/poisoning , Drug Overdose/therapy , Hematopoietic Stem Cell Transplantation/adverse effects , Adult , Cyclosporine/therapeutic use , Erythrocyte Transfusion , Female , Hematopoietic Stem Cell Transplantation/methods , Humans , Immunosuppressive Agents , Plasma Exchange
6.
J Clin Microbiol ; 49(4): 1674-5, 2011 Apr.
Article in English | MEDLINE | ID: mdl-21270218

ABSTRACT

Posaconazole is widely used for prophylaxis against invasive fungal infections in patients undergoing myeloablative therapy. Disseminated fusariosis is a serious invasive mold infection in such patients. Preclinical and clinical studies indicate activity of posaconazole against Fusarium. We describe two cases of disseminated fusariosis that occurred despite posaconazole prophylaxis.


Subject(s)
Chemoprevention/methods , Fusarium/isolation & purification , Mycoses/diagnosis , Mycoses/microbiology , Triazoles/therapeutic use , Adult , Female , Humans , Immunocompromised Host , Male , Middle Aged , Mycoses/prevention & control
7.
Nucl Med Commun ; 32(1): 17-22, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21166089

ABSTRACT

BACKGROUND: Radiotherapy (RT) and chemotherapy are important treatment modalities for a variety of malignant tumor types. During therapy for malignant diseases, often the limitation for further therapy is determined by the capability of the bone marrow to withstand radiochemotherapeutic effects. Evaluation of hematologic toxicity is commonly performed with peripheral blood counts, and occasionally, sampling of marrow through a bone marrow biopsy. Neither method provides a comprehensive assessment, as bone marrow biopsy is invasive, and both are subject to sampling variability. Fluorine-18-3'-fluoro-3'-deoxy-L-thymidine-PET (18F-FLT-PET) is a noninvasive method and related to the rate of DNA synthesis and visualizes the high cycling activity of hematopoietic cells in the bone marrow compartment. To prove the clinical consistency of marrow function and imaging, we investigated populations of patients typically seen in clinical practice, after radiation and chemotherapy. In this feasibility study, patients were evaluated (i) to prove the ability of visualization and quantification of the activity of the bone marrow compartment with 18F-FLT-PET and (ii) to examine the effect of RT and chemotherapy on bone marrow activity and the correlation with clinical findings. METHODS: Bone marrow activity in the cervical region of 10 patients with laryngeal carcinoma who received a mean total dose of 68 Gy (range 30-41 fractions) was evaluated with 18F-FLT-PET, before and 1 month after RT. Whole body FLT images were assessed in nine patients with nonseminomatous testicular germ cell tumor, before and 6 months after the last chemotherapy, consisting of four courses of bleomycin, cisplatin, and etoposide. The maximum standardized uptake value (SUVmax) was used to quantify FLT uptake in bone marrow at the standard bone marrow regions. RESULTS: A significant decrease in 18F-FLT-PET uptake was observed in all the studied laryngeal carcinoma patients in the cervical region after RT of the adjacent bone marrow compartment. Tumor stage and additional field-of-view of RT were inversely related to the 18F-FLT uptake in bone marrow. The mean 18F-FLT SUVmax before RT was 3.0+/-1.34 and after RT was 1.94+/-0.60 (P=0.013). The mean 18F-FLT SUVmax of the spine (Th5-Th12) regions outside the field-of-view of RT were stable and reproducible and not significantly different (5.56+/-1.56 vs. 5.16+/-1.35, P=0.16). Chemotherapy did not result in a significant difference of whole body SUVmax value, with a mean SUVmax of 4.99+/-1.15 prechemotherapy, and a mean SUVmax of 5.28+/-1.0 postchemotherapy (P=0.21). Laboratory analysis of the hematologic parameters confirmed repopulation of the bone marrow. CONCLUSION: 18F-FLT uptake in the bone marrow decreases after RT, but not after chemotherapy. We conclude that 18F-FLT-PET is a potential noninvasive tool that can be used in the assessment of quantification of cellular division in the hematopoietic organ.


Subject(s)
Bone Marrow/drug effects , Bone Marrow/radiation effects , Dideoxynucleosides , Drug-Related Side Effects and Adverse Reactions , Positron-Emission Tomography , Radiotherapy/adverse effects , Adult , Aged , Feasibility Studies , Humans , Laryngeal Neoplasms/diagnostic imaging , Laryngeal Neoplasms/drug therapy , Laryngeal Neoplasms/radiotherapy , Male , Neoplasms, Germ Cell and Embryonal/diagnostic imaging , Neoplasms, Germ Cell and Embryonal/drug therapy , Neoplasms, Germ Cell and Embryonal/radiotherapy , Retrospective Studies , Testicular Neoplasms/diagnostic imaging , Testicular Neoplasms/drug therapy , Testicular Neoplasms/radiotherapy
8.
J Immunol Methods ; 359(1-2): 47-55, 2010 Jul 31.
Article in English | MEDLINE | ID: mdl-20540945

ABSTRACT

Progress has been slow in defining molecular requirements for human B lymphopoiesis in part because of differences from experimental animals and also because of the lack of culture conditions that efficiently support the process. We recently found that human CD10+ lymphocytes were produced when CD34+ hematopoietic stem and progenitor cells were cultured in contact with human mesenchymal stem cells (hMSC). Further investigation revealed that it occurred even when progenitors were separated from hMSC by membrane filters. Experiments with neutralizing antibodies suggested that important heat labile factors produced by hMSC are unlikely to be IL-7, TSLP, CXCL12 or hemokinin-1. Further manipulation of culture conditions revealed that optimal lymphopoiesis required careful selection of fetal calf serum lots, maintenance of high cell densities, as well as recombinant cytokines (SCF, FL and G-CSF). G-CSF was particularly important when adult bone marrow rather than umbilical cord blood derived CD34+ cells were used to initiate the cultures. These improved methods should facilitate identification of molecules that can be used to speed regeneration of the humoral immune system following chemotherapy and might suggest ways to inhibit growth of B lineage malignancies.


Subject(s)
B-Lymphocytes/cytology , Coculture Techniques/methods , Culture Media, Conditioned/chemistry , Lymphopoiesis , Animals , B-Lymphocytes/immunology , Cell Separation , Cells, Cultured , Flow Cytometry , Humans , Mice , Mice, SCID , Stromal Cells , Transplantation, Heterologous
SELECTION OF CITATIONS
SEARCH DETAIL
...